Updated Jul 16, 2026
RHOADS ANN D has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.40M.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | GMED | GLOBUS MEDICAL INC | M — Option exercise | 25.0K | $26.27 | $657K |
| 2026-06-02 | QDEL | QuidelOrtho Corp | A — Grant or award | 6.8K | $0.00 | |
| 2026-05-27 | QDEL | QuidelOrtho Corp | A — Grant or award | 234 | $0.00 | |
| 2026-05-27 | QDEL | QuidelOrtho Corp | A — Grant or award | 1.2K | $0.00 | |
| 2026-01-29 | RPTX | Repare Therapeutics Inc. | D — Derivative transaction | 4.0K | — | |
| 2025-11-10 | GMED | GLOBUS MEDICAL INC | S — Open-market sale | 2.0K | $85.00 | $170K |
| 2025-11-10 | GMED | GLOBUS MEDICAL INC | S — Open-market sale | 8.0K | $81.00 | $648K |
| 2025-09-15 | GMED | GLOBUS MEDICAL INC | S — Open-market sale | 10.0K | $58.46 | $585K |
| 2025-05-24 | QDEL | QuidelOrtho Corp | A — Grant or award | 109 | $0.00 | |
| 2025-05-24 | QDEL | QuidelOrtho Corp | A — Grant or award | 546 | $0.00 | |
| 2025-05-22 | QDEL | QuidelOrtho Corp | A — Grant or award | 4.9K | $0.00 | |
| 2025-05-18 | QDEL | QuidelOrtho Corp | A — Grant or award | 128 | $0.00 | |
| 2025-05-18 | QDEL | QuidelOrtho Corp | A — Grant or award | 427 | $0.00 |
RHOADS ANN D is a corporate insider — currently tracked as Director of QuidelOrtho Corp (QDEL). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.40M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RHOADS ANN D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.